Probiotic nasal spray in prevention of COVID-19 and other common respiratory viruses
Phase 3
Recruiting
- Conditions
- Asthma.Asthma
- Registration Number
- IRCT20200117046164N2
- Lead Sponsor
- research and technology office of Mashhad university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Asthmatic children
Exclusion Criteria
Positive history of COVID-19
Autoimmunity
Malignancy
Complication after nasal spray use
Unwilling to continue participation in trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Investigation of preventive effect of probiotic nasal spray in incidence of upper respiratory infection. Timepoint: Every two weeks until one month. Method of measurement: Checklist of signs and symptoms.;Axillary temperature above 38 Celsius degree. Timepoint: Every two weeks until one month. Method of measurement: Mercury thermometer placed in axillary space.;Exacerbation of Respiratory symptoms. Timepoint: Every two weeks until one month. Method of measurement: Checklist of symptoms.;Development of gasterointestinal symptoms. Timepoint: Every two weeks until one month. Method of measurement: Checklist of symptoms.;Abnormality in smell or gestatory senses. Timepoint: Every two weeks until one month. Method of measurement: Checklist of symptoms.
- Secondary Outcome Measures
Name Time Method